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Abstract
Background: Uromodulin is the most abundant protein found in the urine of mammals. In an
effort to utilize the uromodulin promoter in order to target recombinant proteins in the urine of
transgenic animals we have cloned a goat uromodulin gene promoter fragment (GUM promoter)
and used it to drive expression of GFP in the kidney of transgenic mice.
Results: The GUM-GFP cassette was constructed and transgenic mice were generated in order
to study the promoter's tissue specificity, the GFP kidney specific expression and its subcellular
distribution. Tissues collected from three GUM-GFP transgenic mouse lines, and analyzed for the
presence of GFP by Western blotting and fluorescence confirmed that the GUM promoter drove
expression of GFP specifically in the kidney. More specifically, by using immuno-histochemistry
analysis of kidney sections, we demonstrated that GFP expression was co-localized, with
endogenous uromodulin protein, in the epithelial cells of the thick ascending limbs (TAL) of Henle's
loop and the early distal convoluted tubule in the kidney.
Conclusion: The goat uromodulin promoter is capable of driving recombinant protein expression
in the kidney of transgenic mice. The goat promoter fragment cloned may be a useful tool in
targeting proteins or oncogenes in the kidney of mammals.
Background
Uromodulin is the most abundant protein in the urine of
all placental mammals, with approximately 50–200 mg
released per day. It is an 85-kD glycosylphosphati-dyli-
nositol (GPI)-anchored glycoprotein secreted from the
epithelial cells of the thick ascending limbs (TAL) of
Henle's loop and the early distal convoluted tubule in kid-
ney [1]. Uromodulin has an identical amino acid
sequence, immunologic cross-reactivity and tissue locali-
zation as Tamm-Horsfall protein (THP) [2]. Physiological
functions of uromodulin have remained elusive, but
recent knock-out studies have suggested that it plays a role
in defense against urinary tract infection [3,4]. It may also
have an immuno-suppressive role [5]. The uromodulin
gene promoter has been cloned from human, bovine, rat
and mice species [6-8]. The abundance of the uromodulin
protein in urine makes the uromodulin promoter a good
candidate for driving the production of recombinant (rc)-
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proteins in the kidney and eventual excretion into the
urine of transgenic animals (mice, goats, etc.). The poten-
tial of targeting rc-proteins in the urine may have advan-
tages over the more widely used mammary system. Rc-
protein may be harvested right after birth for both sexes
from a rather simple medium. However, for such a system
to be effective, expression levels should be in the range of
0.5–1 g/L to satisfy commercial applications. To date hGH
is targeted into mouse urine using mouse uroplakin II at
~0.5 µg/mL [9]. The same promoter has been used to tar-
get the human granulocyte macrophage-colony stimulat-
ing factor (hGM-CSF) to the kidney of transgenic mice
with the urine secretion level up to 180 ng/mL [10]. Secre-
tion of rc-alpha1-antitrypsin in mouse urine at levels as
high as 65 µg/mL has been achieved using the human uro-
modulin promoter [11].
As a first step in further exploring the production of rc-
proteins in the urine of transgenic animals, we cloned a
goat uromodulin gene promoter fragment, fused it to a
GFP reporter gene and studied GFP targeting and distribu-
tion in the kidney and more specifically in the epithelial
cells of the TAL of Henle's loop and the early distal convo-
luted tubule.
GFP is an important tool in molecular and cellular biol-
ogy as a transcriptional reporter, fusion tag, or biosensor.
It is considered as an almost ideal in vivo reporter gene,
because it does not interfere with cell vitality. It is highly
sensitive and it can be easily detected using fluorescence
microscopy.
Results
Cloning and characterization of the goat uromodulin gene 
promoter and its partial 3' end
A 3.7 kb fragment of the goat uromodulin gene fragment
containing a 1.5 kb 5' flanking region, exon 1, intron 1,
exon 2 and part of intron 2 was cloned by PCR genomic
walking based on the bovine sequence [7]. The goat uro-
modulin promoter proximal end shares 95 % identity
with bovine uromodulin gene promoter sequence [7]. The
potential transcription initiation site as well as DNA tran-
scription factor binding sites of the goat uromodulin pro-
moter fragment was deduced by comparison with the
bovine promoter sequence (Figure 1). The proximal 1.5
kb 5'-flanking region contains typical eukaryotic pro-
moter elements including two CCAAT boxes at position -
65 and position -558, a TATA box at position -30, and the
conserved sequence TGTAAAAGG (nucleotides -3 to +6).
The proximal 5'-flanking region also contains several
putative binding sites for known transcription factors
such as CEBPB, NFAT, MZF1, SOX5, TCF11, GATA1, IK2
and DELTAEF1, etc., as analyzed with MatInspector V2.2
[12]. In addition, several consensus binding sites for acti-
vator protein-1 (AP-1) are present.
A 2.7 kb fragment of the goat uromodulin gene 3' end was
also cloned using PCR genomic walking and degenerate
primers designed based on conserved nucleotides
between bovine and human [2] uromodulin sequences.
The cloned 3' end fragment contains part of exon 10,
intron 10 and exon 11 including the 3' untranslated
region and a potential polyadenylation site (AATAAT).
Assignment of exon/intron boundaries was achieved by
comparison to the bovine sequence [7].
FISH analysis, performed using the 1.5 kb fragment of the
goat uromodulin promoter as a probe, revealed that the
gene was localized on goat chromosome No. 25 (25q14-
17). Chromosome assignment was performed using a
known BAC goat genomic clone as a marker [13] (Figure
2).
Characterization of mice transgenic for goat uromodulin-
GFP construct
In order to test the functionality of the cloned goat uro-
modulin promoter we generated transgenic mice using
expression DNA cassette GUM-GFP (Figure 3) in which 2
copies of the chicken β -globin insulator sequences were
fused 5' upstream to the 1.5 kb fragment of the GUM pro-
moter. Three transgenic founder mice were mated with
wild type mice and tail DNA samples from the F1 and F2
offspring were analyzed by PCR and Southern blot (Figure
4). Digestion with AflII resulted in a 2.8 kb fragment
which includes 500 bp of the insulator sequence, the pro-
moter region and the full length of the GFP cDNA. The
transgene may be truncated in 99-122-1M-1B1 mouse as
the major hybridizing band appeared smaller in size (Fig-
ure 4). Approximately 50 % of the F1 littermates were
identified as transgenic. Thus, the gene construct was
transmitted according to the Mendelian rules of inherit-
ance. The three transgenic founder lines were viable and
fertile.
The production of the GFP transgenic mice was through
germline random integration. In this way the transgenic
expression pattern would likely be reproducibly observed
in F1 and subsequent generations. This approach may
eliminate the problem of mosaic expression and, in most
cases, the transgenic lines will have correct patterns of
expression, mimicking those of endogenous uromodulin
gene from which the promoter was derived. However, var-
iable transgenic expression could still occur among differ-
ent transgenic lines, attributed to a chromosomal position
effect [14]. To address this problem, efforts have been
made in transgenic animals by using certain chromo-
somal controlling elements, such as locus control region
from the globin gene cluster [15,16] and matrix attach-
ment region from the chicken lysozyme gene [17]. The
inclusion of the two copies of the upstream sequence of
the chicken β -globin gene, used as an insulator [15],BMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
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might have stabilized the GFP expression in kidney of the
transgenic mice developed in this study.
Expression of the GFP transgene in tissues of transgenic 
mice
In order to analyze expression of GFP, extracts from vari-
ous tissues (lung, heart, kidney and liver, etc.), dissected
from a transgenic mouse as well as a negative control,
were subjected to Western blotting analysis using a poly-
clonal anti-GFP antibody (Figure 5). The result demon-
strated that the GUM promoter directed kidney specific
expression of the reporter gene since GFP expression was
identified only in kidney extracts but not in lung, heart
and liver.
Cellular localization of GFP reporter gene in the kidney 
cells of mice transgenic for GUM-GFP
It is established that uromodulin protein is expressed
exclusively in the epithelial cells of the TAL of Henle's
loop and the early distal convoluted tubule in the kidney
[18]. It can, therefore, be used as an ideal marker for iden-
tifying these epithelial cells. Since GFP expression in the
transgenic mice generated was under the control of the
goat uromodulin promoter we reasoned that GFP would
co-localize within the same epithelial cells that normally
express endogenous uromodulin. Immunohistochemistry
analysis of cryo-sections of kidneys dissected from the
transgenic mice using an anti-human uromodulin anti-
body confirmed that expression of the GFP marker
Sequence comparison of the proximal 5' -flanking regions of goat and bovine uromodulin genes Figure 1
Sequence comparison of the proximal 5' -flanking regions of goat and bovine uromodulin genes. Identical nucle-
otides are indicated dashed. The putative transcriptional start site of the goat promoter (nt 1428) is in bold, deducted from the 
known bovine start site (nt 591, bold). TATA, CCAAT boxes and other potential binding sites of transcription factors are 
underlined. The nucleotide sequences of the goat uromodulin gene promoter and the goat uromodulin gene partial 3' end are 
available in the GenBank Database under the accession numbers AY702660 and AY702661, respectively.
Bovine ........................................................................................................................ 0
Goat GACATTCCCACCTAGGATTGAGAAAAAGAATATTAAGAACTTTTATTTTCTTCTGAAGTTATAGCAAAGAAAGGGGAAAAAAAAAAACATTCTTATGGGGGATAAACGGGCAAAGGATAC 120
CEBPB HNF3B NFAT GKLF HFH2 MZF1 GATA1
Bovine ........................................................................................................................ 0
Goat AAACAGTTCAGAAAAGAATAAATAGTAAGCAAATGAAAAGATAACTTCCTTTTTCATCAAAGAACTGCAAAAGTAAATAATGATAAGATGTTTCTCACTTTTCCACAAAGATGAAAGTTA 240
EVI1/GATA1 GATA1 CEBPB
Bovine ........................................................................................................................ 0
Goat ATGCCCAGGGTGGCTGAGTACTGTGCTGGGATTGTGAACTAACTGTTATAGATCTCTCTGGGGTGCTGTTTGGGAAGAAACATCGCTGAAAACTGAGCTACCTCTTTTCCTATGAAATTC 360
CDPCR3HD LYF1 NFAT MZF1
Bovine ........................................................................................................................ 0
Goat CCCTGAGGAGGTGAGTGAGCCGCTGCTGATCGTCACCCGAGCACTAGGCCAGACAGAAGGAGAAAGCCCTCAAAGAGGCAATGCTGTGGATCACTGTCATATTTCCTGCTCAGCCTGAGT 480
DELTAEF1 TCF11 NFAT
Bovine ........................................................................................................................ 0
Goat TCACATGTGCCTGATTTTTCTCAATATGGCATTGCCATTAACGTGGAATTAGGTCAGGAGACCTAAGGCTGAACCAAGCCCTGTCATTCTCTGCCCCATGACTGCGCATCACCAAAACAG 600
CEBPB RORA2 TCF11
Bovine ........................................................................................................................ 0
Goat CATCGGCAGTGACTTCCACAGATGGTACCATTGCTATATGCCTTAACTTGCATCATCTCCTTTAATGGCCATAACAATTCTAGGACACGGGTATTCTTGTTTTACAGATGATGAAAATTA 720
AP1FJ SOX5
Bovine ........................................................................................................................ 0
Goat CCTCTGGAAGGAAAATTACTGGCACACAAAAAACGCTGACCAGGATTCAGATAGACTGACTCCAAAGTCAGTCTGTTCATCTACAAAATTATCTACTTCTCAAGGACCTTCCTTCATGGG 840
NFAT GATA1 AP1 S8 IK2
Bovine ......--------------------------------------------gc--t-----------------g--------------------c------c------------a------ 114
Goat AATTCAAATTTCTTGATTCACAGAGCATCTGGTCCAATGATGTCTGAATTATCTGCTGTCTCTGACCTTCAGCCATTCTCAGCTCCTTTCCTGATCACATTGGGACCCCAGGGGAGCTGG 960
S8/GATA1 IK2 MZF1
Bovine t----c-ca--------ga-c-----------c-g--------------t------ca---------g---------------------------------------------------- 234
Goat CTGAATCTGTGAGGATGACATTTGCTTTGGAATTAAGTGGCCACAAGTACACATCCTGGTGGGGACAATGAGCACCCCTTTTCTCCTGGAGCAGCCTGGCTTCAGATTCTGGCCTCTGCT 1080
MZF1
Bovine -...-------------------------------g-------a---------t-----c---------------------------c-----------a-------------------- 351
Goat TGGCTCCACTTTGTGCTTTTCAATGACCAAGAAAATCCCAGGCCCTTGGAATTGTTTACTCAGTTAATTTCTAACTAAAGAACCTCTTGTTGCCAAAAGGTATAAAACAGAGCCCTTGTA 1200
TCF11 SOX5 TATA
Bovine ---c--------a----------ag----------------------------------------------------------------------------------------------- 471
Goat ACTGTGGGCACAGCTGTGACCCCCATGTCAATCATTTGGGGTCTCTACCTATTAGGGAAAAGAACAACAACCACCTCACAGCCTAGAAAAGGAAAACACTGTGTCAAAAGGGAAAAATAT 1320
HEN1/AP4 NFAT NFAT
Bovine ---------------------------------------------------a---c------------------------------------t--------------A------------ 591
Goat TCCACCCCCATTAAAATAATTAAGAAACAGAACCAGAGGATCATTGGAGGAGAGATTGCCAGTGGGGGACAGATGTATATATATAGATATGAAAGTCACCTACTTGTAAAAGGATTAATT 1440
S8/NKX25 MZF1 MyoD TATA GATA1 DELTAEF1
Bovine -------------------t-aggctatctgcaga 626
Goat CTACCTTTCTGGTTTCAGGAA.............. 1461BMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
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FISH analysis of R-banded metaphase spreads from peripheral blood with a goat uromodulin promoter probe Figure 2
FISH analysis of R-banded metaphase spreads from peripheral blood with a goat uromodulin promoter probe. 
The arrows indicate the localization of the uromodulin gene on goat chromosome #25, whereas the signal of the BAC clone 
(EPO) was used for chromosome assignment.BMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
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protein co-localized with the endogenous uromodulin
(red-color stained) in the medulla region of the kidney
(Figure 6B, C). It was noteworthy, however, that only a
small proportion of the cells within the medulla region of
the kidney co-expressed both uromodulin and GFP (Fig-
ure 6D–F) with the rest of the cells forming a mosaic
pattern between cells expressing either endogenous uro-
modulin or GFP (Figure 6C). The cellular localization of
endogenous uromodulin and transgenic GFP was in the
plasma membrane and cytoplasmic space, respectively
(Figure 6B, C). The two proteins were not detected in mac-
ula densa and from glomeruli, proximal convoluted
tubules, thin limbs of the Henle's loops, collecting duct,
blood vessels, and the interstitium (data not shown).
Onset of uromodulin expression during embryonic life
We investigated the onset of the endogenous uromodulin
expression during embryonic life and compared it with
the expression of the GFP transgene driven by the GUM
promoter as it has been reported that in human the uro-
modulin protein can be detected after 20 weeks of gesta-
tion [19]. Two GUM-GFP transgenic F1 mice were mated
with wild type females. Pregnant females were euthanized
at days 10–15 of gestation and fetuses were recovered.
DNA extracted from the head of each fetus was used to
identify by PCR the fetuses as transgenic. The transgenic
fetuses as well as negative ones were cryo-sectioned and
whole embryo mounts were examined for the presence of
the GFP transgene and by immunohistochemistry for uro-
modulin positive cells. No endogenous uromodulin or
GFP positive staining was observed on the embryo sec-
tions analyzed, indicating that uromodulin was not
detectable during embryonic stage tested (data not
shown). However, Western blot analysis performed on
the homogenized kidney samples of day 0 pups from a
transgenic mouse line demonstrated that the GFP was
expressed at birth (Figure 7).
Discussion
Transgenic animal technology is a valuable tool for under-
standing gene function. Moreover, the use of transgenic
farm animals for the production of pharmaceutically
important rc-proteins, such as antibodies, anti-clotting
factors, and growth factors, in the mammary gland is also
very well documented [20]. A transgenic animal that
secretes rc-proteins in its urine offers certain advantages
and compliments mammary-gland based rc-protein pro-
duction system. We have chosen to use the goat uromod-
ulin promoter driving the GFP kidney-specific expression
in transgenic mice as a pilot feasibility study for the goat.
Compared with other farm animal species, the goat is one
of the most promising models for commercial production
for rc-proteins and it is used more frequently because of
relatively low cost of maintenance and faster breeding
times as compared with cattle [21,22]. The feasibility of
targeting proteins in the uro-epithelium of bladder and
kidney has been demonstrated [9,23-25]. The present
study further confirms these studies. The practical
outcome of these studies would be to use urine as a biore-
actor system in which rc-proteins could be expressed and
excreted under the control of the goat uromodulin
promoter.
Characterization of targeting the uro-epithelium of blad-
der and the kidney by the use of the uroplakin II or uro-
modulin promoters has been recently initiated as
Schematic drawing of the pING32 transgene, excised from pING32 by digestion with XhoI-SphI Figure 3
Schematic drawing of the pING32 transgene, excised from pING32 by digestion with XhoI-SphI. The lower bars 
indicate the lengths of the PCR products and the primer pairs used for the screening of the transgenic mice.
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Southern blot analysis of AflII digested mouse genomic DNA Figure 4
Southern blot analysis of AflII digested mouse genomic DNA. Lane 1: Dig-labeled Marker VII (Roche). Lane 2 & 11: 
GFP transgene plasmid DNA. Lane 3–9: tail DNA derived from GFP-positive mice. Lane 10: tail DNA from a non-transgenic 
mouse. 7 µg of DNA was loaded in each lane (lanes 3–10). The membrane was hybridized with a Dig-labeled PCR probe 
(Acb504-412, see Figure 3). The arrow indicates the GFP transgene.
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Western blot analysis of protein extracts from tissues of GUE-GFP transgenic mice Figure 5
Western blot analysis of protein extracts from tissues of GUE-GFP transgenic mice. Tissue extracts from a trans-
genic mouse (99-120-2F) and a negative control mouse (99-120-6F) were separated on 4–20 % SDS-PAGE and transferred 
onto the membrane. The GFP positive control was from a cell line with GFP expression. 12 µg of total protein was loaded in 
each lane. A. Immunoreacting bands were detected using a polyclonal anti-GFP antibody (Clontech). B. The same blot was 
reprobed with a mouse monoclonal anti-actin antibody (Chemicon) to show that equal amount of protein was loaded in each 
lane.
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mentioned above. Promoters from erythropoietin [26]
and rennin [27,28], have been used as kidney specific
genetic elements. We report on the tissue specificity of a
goat uromodulin promoter in transgenic mice. The
reporter GFP gene used was co-expressed in the epithelial
cells in the Henle's loop together with the endogenous
uromodulin. Using the same GUM-GFP transgene we
established the concomitant developmental control of the
uromodulin expression and identified that the earliest
stage of GFP expression was detected at birth. The tissue
specificity observed demonstrate that the goat uromodu-
lin promoter fragment cloned is capable of controlling
kidney specific expression of GFP.
Demonstration of expression of the goat uromodulin – GFP transgene and endogenous uromodulin in kidney sections by  immunostaining Figure 6
Demonstration of expression of the goat uromodulin – GFP transgene and endogenous uromodulin in kidney 
sections by immunostaining. (A). H & E kidney TAL region staining of a control non-transgenic mouse. The arrows show 
microstructures with thick walls indicative of the thick segment of the ascending limb of Henle's loop within the TAL region. 
Fixed kidney sections from a negative control mouse (B) and the 99-122-1-A5M transgenic mouse (C) were stained with a pol-
yclonal anti-human uromodulin antibody, followed by treatment with Texas-Red conjugated secondary anti rabbit IgG anti-
body. Expression of endogenous uromodulin in the cells (red) appears in a punctuated pattern, whereas the GFP expression is 
cytoplasmic (green). Immunostaining of similar sections for uromodulin confirmed that expression is restricted to tubular epi-
thelial cells of these structures (B, C) indicated by red. The same sections observed for GFP expression by confocal micros-
copy indicated that expression was restricted to similar structures as in B &C but not co-expressed with the endogenous 
uromodulin staining. As expected GFP was absent in the renal sections obtained from a non-transgenic mouse. Both GFP (D, 
F) (green) and uromodulin (E, F) (red) were co-expressed in cells in the TAL segment (transgenic mouse, 99-122-1-A5M).
AB
F E
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100 µm 100 µmBMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
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It has been reported that small quantities of uromodulin/
THP can be detected in blood using sensitive immu-
noassays [29,30], but it is possible that some proteins in
the serum simply cross-react with the antibody raised
against the uromodulin/THP proteins [31]. The renal
environment appears not to be essential for transcription
of the uromodulin/THP gene or synthesis of the protein.
Support of this stems from the observation that tissue of
rat renal cortex and medulla, when transplanted to the
anterior chamber of the eye, proliferated to form tubule-
like structures [32]. Sections of these implants reacted
with monoclonal antibodies specific for rat uromodulin/
THP by immunohistochemistry [18]. The uromodulin/
THP immuno-cross-reactive material in liver and cerebro-
spinal fluid is suggestive that this protein may be present
extrarenally in all tissues involved in active chloride trans-
port (such as intestinal and liver, etc), however this
finding has not been confirmed either with the use of
monoclonal antibodies or the mRNA presence in these
tissues [2]. In agreement with this, our data, as well as
other recent reports [11,23-25], clearly demonstrate that
the uromodulin promoter is an excellent candidate for
driving foreign proteins expressed specifically in the
kidney.
GFP fluorescence provides an easily visualized marker for
the epithelial cells in whole kidneys dissected in frozen
sections. This eliminates the need to stain with lectins or
antisera to visualize the cells, and therefore allows the
cells to be visualized simultaneously with other structures
in the developing kidney by combined immunohisto-
chemistry/GFP detection. The arrays of the GFP
expression in the kidney cells are of interest (Figure 6).
Normally one would assume that since the goat uromod-
ulin promoter was used to drive the GFP expression the
same cells should express both uromodulin and GFP all
together, however this was only observed in a small pro-
portion of the cells. Due to the copy numbers of the uro-
Western blot analysis of kidney extracts from Day 0 pups, offspring of a GUM-GFP transgenic F2 mouse Figure 7
Western blot analysis of kidney extracts from Day 0 pups, offspring of a GUM-GFP transgenic F2 mouse. Kid-
ney extracts (12 µg of total protein loaded in each lane) from 99-120-2 and 99-122-1A3 were used as positive controls, 
whereas 99-120-6 was used as a negative control. GFP immunoreacting protein was detected using the polyclonal anti-GFP 
antibody (Clontech) in 2 out 4 Day 0 pups, offspring of a transgenic F2 mouse, 00-074-1A2B8M, bred with a wild type mouse.
42
30
kD 99-120-2
(+)
99-120-6
(-)
99-122-1A3
(+)
00-074-1A2B82
00-074-1A2B83
00-074-1A2B84
(-)
00-074-1A2B85
(-)BMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
Page 10 of 13
(page number not for citation purposes)
modulin promoter integrated in the genome of the
transgenic mice it is possible that it competes with the
endogenous uromodulin promoter for the transcriptional
regulatory factors in the same cells and as a result it may
compromise endogenous uromodulin expression. A sim-
ilar example has been reported for expression of a Bombyx
cytoplasmic actin gene in cultured Drosophila cells to show
that expressions of endogenous and recombinant actin
genes are not independent [33]. When the Bombyx cyto-
plasmic actin A3 genes were introduced into Drosophila
cells, the amounts of transcripts from the endogenous
cytoplasmic Act 5C and Act 42A actin genes decreased
proportionally. Furthermore, in cell lines with stably inte-
grated A3 genes, the increased accumulation of endog-
enous cytoplasmic actin mRNAs is accompanied by a
decrease in the A3 mRNA accumulation: thus when the
transcription of resident genes is stimulated, the expres-
sion of the transgene is reduced. This balance suggested a
competition for the factors involved in the transcription
of the cytoplasmic actin genes.
The appearance of uromodulin/THP coincides develop-
mentally with maturation of the TAL of Henle's loop [18].
It has been reported that it is present at eight weeks in the
human fetal kidney, two days pre-term in rat [34], and
three days pre-term in hamster kidney [35]. Urine from
fetal kidney contributes to amniotic fluid from 12 to 14
weeks of gestation [36]. While uromodulin/THP has been
described in human amniotic fluid near term by several
researchers, studies in mid-term amniotic fluid have been
more equivocal [37-39]. Kumar et al. have tested amniotic
fluid from four patients at 16 weeks and could not detect
uromodulin/THP by an enzyme-linked immunosorbent
assay in which the lower limit of detection was 20 ng/mL
[18]. The earliest stage in which we were able to detect
GFP expression driven by uromodulin promoter in trans-
genic mice was at birth (Figure 7). Although immunohis-
tochemistry was attempted to examine the expression of
both uromodulin and GFP at earlier embryonic stages nei-
ther could be detected (data not shown). It is likely that
the expression level was not high enough to be visualized
by the method employed, or that there is a species differ-
ence in the ontogeny of the uromodulin protein.
Conclusion
The goat uromodulin gene promoter efficiently targeted
expression of GFP in the kidney of transgenic mice and
more specifically in the epithelial cells of the TAL of
Henle's loop. Expression of GFP was co-localized in cells
expressing endogenous uromodulin. Expression appeared
to be specific to kidney at least among the tissues tested.
Methods
Cloning of the goat uromodulin gene promoter and its 
partial 3' end
PCR was performed using genomic DNA from a standard
Saanen goat as template with two primers deduced from
the conserved regions of human and bovine uromodulin
gene promoters [7]. The sense primer was 5' CAT TCT
CAG CTC CTY TCY TGC 3' and the antisense primer was
5' AGA GAC CCC AAA TGA TTG ACA 3'. A 350 bp PCR
fragment was obtained and sequenced, showing 95 %
identity with the known bovine uromodulin promoter
sequence [7]. The gene-specific primers were designed
from the PCR product to conduct PCR genomic walking
using a goat (standard Saanen breed) genomic DNA
library, created with the Universal Genome Walker Kit
(Clontech). A 3.7 kb PCR fragment was obtained both
from the genome-walking library and the goat genomic
DNA with newly designed gene-specific primers. This frag-
ment contains a 1.5 kb 5' flanking region, exon 1, intron
1, exon 2 and part of intron 2. Similar strategy was
employed for cloning a 2.7 kb fragment of the 3' end. The
initial set of degenerate primers was designed based on
the conserved regions of bovine uromodulin gene.
GUM/GFP plasmid construction
A 1.5 kb fragment of the goat uromodulin promoter was
subcloned into the pGEM-T easy vector (Promega) and a
HindIII-PstI digested promoter insert was ligated with
HindIII-PstI digested CMV-IE and EF-1alpha-less
pCEEGFP [40] to generate pGUMGFP3. Two copies of a
1.2 kb fragment of the chicken β -globin insulator [15],
was digested with XhoI and SalI, and ligated at the XhoI
site, located upstream of the goat promoter fragment in
pGUMGFP, resulting in the final construct, pING32. The
cloned 2.7 kb fragment of the goat uromodulin gene
3'end was not part in the DNA construct used in the gen-
eration of transgenic mice.
Production of uromodulin-GFP transgenic mice
The plasmid backbone of pING32 was removed by XhoI-
SphI digestion and the 5.5 kb uromodulin-GFP transgene
fragment (Figure 3) was gel-purified and microinjected
into the pronuclei of FVB mouse zygotes using standard
techniques [41]. The production and maintenance of
transgenic mice were conducted at the McIntyre Trans-
genic Core Facility of McGill University. Animal studies
were carried out in accordance with the Guide for the Care
and Use of Laboratory Animals as adopted by the U.S.
National Institutes of Health.
PCR analysis
Transgenic mice were detected by PCR analysis of tail
DNA with primers amplifying sequences of the insulator,
the junction sequence between the uromodulin promoter
and GFP. The sense and antisense primers used to amplifyBMC Biotechnology 2005, 5:9 http://www.biomedcentral.com/1472-6750/5/9
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the insulator fragment were 5' AGG AGC ACA GTG CTC
ATC CAG ATC 3' (Acb347) and 5' GAC GCC CCA TCC
TCA CTG ACT 3' (Acb478). The sense and antisense prim-
ers for amplifying the uromodulin promoter-GFP were 5'
GAT CAT TGG AGG AGA GAT TGC CAG TG 3' (Acb504)
and 5' GTC TTG TAG TTG CCG TCG TCC TT 3' (Acb412)
(Figure 3). PCR was performed using the Ready-to-Go™
PCR beads (Amersham-Pharmacia Biotech) under the fol-
lowing conditions: 94°C/2 min, 36 cycles of 94°C/30 s,
60°C/45 s, 72°C/45 s and finally 72°C/5 min in a PTC-
100™ Programmable Thermal Controller (MJ Research,
Inc.). The PCR products were visualized on a 1 % agarose
gel and analyzed by FluorChem™ 8000 Advanced
Fluorescence, Chemiluminescence and Visible Light
Imaging System (Alpha Innotech Corporation).
Southern blot analysis
Genomic DNA extracted from mouse tail was digested
with AflII, subjected to electrophoresis on a 1 % agarose
gel and transferred to a Nylon membrane (Roche), posi-
tively charged. The membrane was hybridized using a
DIG Easy Hyb buffer (Roche) at 42°C overnight contain-
ing a PCR-generated probe, labeled by the PCR DIG probe
synthesis kit (Roche). This fragment was amplified using
the Acb504/412 set of primers amplifying a 490 bp frag-
ment. The membrane was washed once at room tempera-
ture with 2 × SSC, 0.1 % SDS for 5 min, three times with
0.5 × SSC, 0.1 % SDS at 68°C for 15 min per wash. Detec-
tion of hybridization signals was by using the CDP-Star™
substrate (Roche). The membrane was analyzed by the
FluorChem™ 8000 System (Alpha Innotech Corporation).
Fluorescent In Situ Hybridization (FISH)
The method used essentially was as described [42,43].
Briefly, R-banded chromosomes spreads were prepared by
synchronization of goat peripheral blood lymphocytes
cultured in RDG medium with thymidine for 18 h. A DNA
probe including the 1.5 kb goat uromodulin promoter
fragment was labeled with a Bionick labeling kit (Life
Technologies Inc). Hybridization medium containing
biotinylated probe and genomic goat DNA, was placed on
each slide and covered with a plastic film. The slides were
incubated overnight at 37°C in a humidified chamber
with 50 % (v/v) formamide/2 × SSC followed by wash
steps. The slides were incubated for 45 min at 37°C with
rabbit anti-biotin Enzo (1 % in modified PBS: PBS with
0.1 % Tween™ 20 and 0.15 % BSA added), and rinsed
twice in modified PBS. The samples were incubated with
a mouse anti-rabbit biotin-conjugated antibody (0.75 %
in modified PBS, Pierce) and rinsed. Slides were stained
with Propidium Iodide, mounted and covered with a cov-
erslip. Samples were observed under an Olympus micro-
scope B × 40 using an appropriate combination of filters
for fluorescein labeling.
Western blot analysis
Tissue extracts from kidney, lung, heart, liver and bladder
dissected from uromodulin-GFP transgene positive mice
as well as negative controls were prepared by homogeni-
zation in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1
mM EDTA, 1 mM DTT, pH 7.5) containing a tablet of a
proteinase inhibitor cocktail (Roche). Proteins recovered
in the supernatants following a centrifugation step were
separated by SDS-PAGE on a 4–20 % Tris-Glycine polyacr-
ylamide gel (precasted, Invitrogen) and electrophoreti-
cally transferred to an ECL nylon membrane (Amersham).
After pre-incubation of the membrane for 1 h in TBST
[0.24 % (w/v) Tris, 0.8 % (w/v) NaCl, pH 7.6, 0.05 % (v/
v) Tween™ 20] containing 5 % nonfat milk, it was incu-
bated in TBST containing a polyclonal anti-GFP antibody
(Clontech) at a 1:100 dilution, followed by incubation in
TBST containing a HRP-conjugated secondary anti-rabbit
IgG antibody (Promega) at 1: 5,000 dilution. Immuno-
complexes were detected with the ECL chemilumines-
cence detection kit (Amersham). Analysis of the
immunoreactive bands on the blots was performed with
FluorChem™ 8000 System (Alpha Innotech Corporation).
Immunohistochemistry
Mice transgenic for the uromodulin-GFP transgene, as
well as a negative control, were perfused with 4 % parafor-
maldehyde for fixing the GFP in situ. Kidney and other
tissues were dissected from the perfused mice and cryo-
sectioned with a thickness of 5 µm. Following incubation
of the tissue sections with 5 % goat serum in PBST [PBS,
pH 7.4, 0.05 % (v/v) Tween™] they were incubated in
PBST containing a polyclonal anti-human uromodulin
antibody (BTI) at 1:200 dilution, followed by treatment
with a Texas-Red conjugated secondary anti rabbit IgG
antibody (Molecular Probe). The sections were mounted
with DAKO fluorescence mounting medium (DAKO),
and observed with an Olympus UV-microscope with a
FITC filter (for GFP) and rhodamine filter (for Texas-red).
Confocal fluorescence microscopy
Immuno-stained slides were imaged using a Zeiss LSM
410 confocal scanning laser microscope equipped with
argon-krypton and helium-neon lasers and appropriate
filter sets for independent detection of FITC and Texas
Red. Superimposition of serial sections was used to com-
pare the distribution of each of the labels.
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